Even though payers and providers still struggle to effectively collaborate, health tech vendors can often act as a linking agent to improve outcomes for both sides.
Medtronic developed a way to reduce false alerts through its AccuRhythm™ AI algorithms. The algorithm is applied through cloud-based updates to all LINQ II™ Insertable Cardiac Monitors (ICMs) and helps improve the accuracy of information physicians receive so they can better diagnose and treat abnormal heart rhythms.
To learn more about AccuRhythm AIPlatform, please click here to download an infographic explaining how it works.
Don't miss out on this valuable opportunity to meet and discuss the latest trends and opportunities. Don't miss your chance to save with the Super Early Bird Rate.
The French delegation at BIO on June 13-16 has a compelling story to tell about biopharma and medtech growth and investment in France and the U.S. Here's a preview of some of the companies that will be at the convention, events they will host and why you should check them out.
Ten biotech companies were able to raise more than $500 million in combined financing in the past week. Here's a recap of the funding activity, which spanned AI-based drug discovery, cell therapy clinical research, cancer drug development, and more.
If multicloud is on the rise in other industries and desired by healthcare IT professionals, what's holding them back from deploying it? The answer isn't quite simple, but there are a few significant challenges healthcare organizations are up against. While there may be a challenging road ahead, the payoff of multicloud will be worth it.
RPM as we know it today – with all its advantages – falls short. The reason? Monitoring and alerting alone cannot provide one of the most critical parts of healthcare: care itself.
-Recovered.png?width=1200&height=400&upscale=true&name=DIgital%20Health%20Header(1)-Recovered.png)
No comments